TY  - GEN
AU  - Meisel,Jane L
AU  - Zhao,Jing
AU  - Suo,Aili
AU  - Zhang,Chao
AU  - Wei,Zhimin
AU  - Taylor,Caitlin
AU  - Aneja,Ritu
AU  - Krishnamurti,Uma
AU  - Li,Zaibo
AU  - Nahta,Rita
AU  - O'Regan,Ruth
AU  - Li,Xiaoxian
TI  - Clinicopathologic Factors Associated With Response to Neoadjuvant Anti-HER2-Directed Chemotherapy in HER2-Positive Breast Cancer
SN  - 1938-0666
PY  - 2021///0329
KW  - Adult
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - pharmacology
KW  - Biomarkers, Tumor
KW  - analysis
KW  - Breast
KW  - immunology
KW  - Breast Neoplasms
KW  - genetics
KW  - Carcinoma, Ductal, Breast
KW  - Chemotherapy, Adjuvant
KW  - methods
KW  - DNA Copy Number Variations
KW  - Drug Resistance, Neoplasm
KW  - Feasibility Studies
KW  - Female
KW  - Humans
KW  - Lymphocytes, Tumor-Infiltrating
KW  - Mastectomy
KW  - Middle Aged
KW  - Neoadjuvant Therapy
KW  - Predictive Value of Tests
KW  - Progression-Free Survival
KW  - Receptor, ErbB-2
KW  - antagonists & inhibitors
KW  - Receptors, Estrogen
KW  - Receptors, Progesterone
KW  - Tumor Burden
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.clbc.2019.09.003
ER  -